Related Experiment Video
Updated: Sep 10, 2025

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
Published on: January 22, 2021
SPARC Induces COL1A1/COL3A1 Expressions Representing Aggressive Molecular Cancer-Associated Fibroblasts Signatures
Yusuke Nie1, Yoshiki Fujiyama1, Shumpei Shibaki1
1Division of Advanced Surgical Oncology, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Background:
Secreted protein, acidic and rich in cysteine (SPARC) may play an important role in tumor microenvironment (TME) contribution to metastasis, however molecular mechanism of SPARC contribution to TME remains elusive.
Experimental Design:
In this study, SPARC molecular status was explored for its clinical and functional relevance to metastasis in the context of its stromal overexpression, which may represent colorectal cancer (CRC) progression.
Results:
SPARC expression was highly specific to cancer stroma of CRC tumors (GSE35608) and exhibited prognostic relevance. SPARC knockdown (KD) in cancer-associated fibroblasts (CAFs) resulted in diminished metastatic phenotypes, accompanied by robust suppression of COL1A1/COL3A1 expressions and multiple secretome genes. Among the secretome genes, CSF1 was closely associated with stromal SPARC expression, and it was demonstrated that the CSF1/CSF1R axis was required for SPARC-induced cancer invasion. Comprehensive selection by stromal specificity and its SPARC association identified CAF-associated genes (CAFGs), including classical CAFs markers and COL family genes, which were uniquely enriched as higher priority for prognosis. These findings suggest that SPARC-mediated induction of COL family genes and secretome in the TME may be primarily featured against the host rather than be protective.
Conclusions:
Our present findings may aid in simplifying molecular understanding of aggressive TME and enrich bona-fide therapeutic targets for cancer metastasis.
Insights
Secreted protein, acidic and rich in cysteine (SPARC) promotes colorectal cancer metastasis by altering the tumor microenvironment (TME). Targeting SPARC and its associated genes offers potential therapeutic strategies for aggressive cancers.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Secreted protein, acidic and rich in cysteine (SPARC) is implicated in tumor metastasis, but its precise role in the tumor microenvironment (TME) is not fully understood.
- Stromal overexpression of SPARC may indicate colorectal cancer (CRC) progression.
Purpose of the Study:
- To investigate the clinical and functional significance of SPARC in colorectal cancer (CRC) metastasis.
- To elucidate the molecular mechanisms by which SPARC influences the tumor microenvironment (TME).
Main Methods:
- Exploration of SPARC molecular status in CRC tumors.
- SPARC knockdown in cancer-associated fibroblasts (CAFs).
- Analysis of gene expression (COL1A1/COL3A1, secretome genes) and the CSF1/CSF1R axis.
Main Results:
- SPARC expression is specific to CRC stroma and has prognostic value.
- SPARC knockdown in CAFs reduced metastatic phenotypes and suppressed COL1A1/COL3A1 and secretome genes.
- The CSF1/CSF1R axis is crucial for SPARC-driven cancer invasion.
- CAF-associated genes (CAFGs), including COL genes, are prognostic indicators.
Conclusions:
- SPARC promotes metastasis by inducing collagen and secretome genes in the TME, acting detrimentally to the host.
- These findings enhance understanding of aggressive TME and identify potential therapeutic targets for cancer metastasis.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Cancer Cell Migration through Invadopodia
Abnormal Proliferation
Regulation of Hematopoietic Stem Cells
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

